Hematology
Hematology
The Hematology department brings together all adult hematology activities of the Caen Normandy University Hospital and the François Baclesse Center .
The Hematology department brings together all adult hematology activities of the Caen Normandy University Hospital and the François Baclesse Center .
Consultations & Team
Service composition
The paramedical team is composed of:
- from a day hospital coordinating nurse,
- from a transplant coordinating nurse,
- from a CAR-cell coordinating nurse,
- from an advanced practice nurse (APN)
- of 43 State-Certified Nurses,
- of 22 nursing assistants,
- of 7 Hospital Service Agents,
- of 8 Medical-Administrative Assistants
- and 2 healthcare managers.
Our services
You will have access to expert doctors specializing in various fields of blood, bone marrow or lymph node diseases.
The Hematology department and its teams guarantee access to the best treatments for hematological diseases, both malignant and benign, for patients in Western Normandy, through standard treatments or within the framework of therapeutic innovation and clinical research. This healthcare service is provided within a university setting and through continuing education programs, ensuring the quality of ongoing training for healthcare professionals.
The institute also offers suitable access to support care in collaboration with the relevant services (psychologist, dietician, reflexologist, social worker, etc.) and in close connection with AFSOS (French-speaking Association for Supportive Oncology Care).
In this Institute we bring our expertise to the care of patients with acute and chronic Leukemias, Lymphomas, Myelomas, Myelodysplasias, etc., as well as non-malignant hematological pathologies.
This unit comprises 14 beds and accommodates patients who are to receive an allogeneic hematopoietic stem cell (or bone marrow) or those with acute leukemia.
You will be hospitalized in a private room with specific air treatment to ensure your safety. You will have access to a television (for a fee) and Wi-Fi.
Hematologists are available to you and will ensure the continuity of your medical care in collaboration with all paramedical staff, the administrative team, and the activity coordination team
- Dr. Hyacinthe Johnson-Ansah, Hospital Practitioner
- Dr. Sylvain Chantepie, Hospital Practitioner
- Ms. G. Pape, Healthcare Manager
If you wish to meet with the doctors or the unit manager for a relative hospitalized in this unit or for yourself, you can contact the secretariat at 02 31 27 27 59
If you would like to have news of one of your relatives hospitalized in this unit, you can contact us at 02 31 27 25 42.
If you would like more information on how this unit works, you can contact
- Ms. G. Pape (healthcare manager) at 02 31 27 25 44
- Ms. F Champs (registered office activity coordinator) at 02 31 27 23 61
This unit has 12 beds and accommodates patients
- to receive an autologous hematopoietic stem cell transplant,
- suffering from lymphoma, myeloma,
- rare diseases,
- benign hematological pathologies
- with post-treatment complications
- etc…
You will be hospitalized in a private room.
You will have access to a television (access to which is charged) and Wi-Fi.
Specialist doctors are available to you and will ensure the continuity of your medical care in collaboration with all paramedical staff, the secretariat and the coordination of activities.
- Professor Gandhi Damaj, University Professor, Hospital Practitioner
- Dr. Hippolyte Bardet, Hospital Practitioner
- Dr. Simon Laurent, Head of Clinic
- Ms. G. Pape, Healthcare Manager
If you wish to meet with them regarding a relative hospitalized in this unit, you can contact them at 02 31 27 21 24
If you would like to have news of one of your relatives hospitalized in this unit, you can contact us at 02 31 27 25 40
If you would like more information on how this unit works, you can contact
Ms. Gwenaelle Pape, (Healthcare Manager) at 02 31 27 25 44
It comprises two units
- Day Hospitalization Unit: 9 beds.
This unit admits patients Monday to Friday afternoons for scheduled treatments of lymphoma, myeloma, leukemia, rare diseases, benign hematological conditions, and occasionally patients requiring scheduled investigations necessitating hospitalization for several days (between 1 and 5 days). - Day Hospitalization Unit: 18 beds and chairs.
This unit admits patients Monday through Friday afternoons for scheduled treatments for lymphoma, myeloma, leukemia, rare diseases, benign hematological conditions, and patients requiring scheduled same-day investigations.
Five doctors are at your disposal and will ensure the continuity of your medical care in collaboration with all the paramedical staff, a secretariat and a coordination of activities.
- Dr. Stéphane Chèze, Hospital Practitioner
- Dr. Baptiste Delapierre, Hospital Practitioner
- Dr. Nicole Frenkiel, Hospital Practitioner
- Dr. Margaret Macro, Hospital Practitioner
- Dr. Paul Gauberti, Head of Clinic
If you would like more information on how this unit works, you can contact
- Mr. Alexis Moreau, (Healthcare Manager) at 02 31 27 21 36 or 06 98 38 72 89
- Or contact theHDJ at 02 31 27 25 47
This unit has 4 beds and accommodates patients who need to receive hematopoietic stem cell collection for autologous transplantation, allogeneic transplantation or CAR T-cell therapy; as well as patients receiving plasmapheresis, photopheresis or erythrapheresis.
You will be hospitalized in a private room with 2 beds, and you will have access to a television (access to which is charged) and Wi-Fi access.
A doctor is available to you and will ensure the continuity of your care in collaboration with all the paramedical staff authorized for this activity as well as the coordinating nurses
- Dr. Farah Khemir, Hospital Practitioner
- Dr. H. Johnson-Ansah, Hospital Practitioner
If you would like more information on how this unit works, you can contact
- Ms. G. Pape, (Healthcare Manager) at 02 31 27 25 44
- Ms. M. Saliot( RegisteredNurse Coordinator) at 02 31 06 51 95
- Ms. CHAMPS, (Registered Nurse Coordinator) 02 31 27 23 61
There are slots for nurse announcement consultations on Tuesdays and Thursdays.
Four nurses are trained for this activity. If the patient wishes, a family member or designated contact person can be present on the day the diagnosis is announced. The healthcare professional listens to the patient to understand their level of information and concerns. They summarize what was said during the medical consultation, explain the treatment process, and, most importantly, assess the patient's needs for supportive care.
The clinical pharmacy activity within the Lower Normandy Hematology Institute (IHBN) is structured around different missions:
- Pharmaceutical analysis of prescriptions from the department.
- Medication reconciliation at admission and discharge involves creating a comprehensive list of medications taken by the patient before hospitalization and comparing it with the initial prescription written in the ward. The process is the same at discharge, comparing the patient's usual medications with the discharge prescription. Furthermore, this discharge prescription is shared with community healthcare professionals, thus strengthening the link between community and hospital care.
- The return of medication to the department for targeted patients.
The clinical pharmacist provides patients with information about their medication regimen through pharmaceutical consultations (initiation/follow-up). These consultations are conducted for patients starting oral chemotherapy, as well as patients enrolled in clinical research protocols. These consultations can be conducted in person or remotely (teleconsultation, telephone interview). Following these consultations, information is shared with various healthcare professionals, strengthening the link between community and hospital care.
In addition, the clinical pharmacist has an advisory role with the medical and paramedical team and reminds them of good practices for prescribing and administering medication.
The clinical pharmacist is an integral part of the medical team of the care unit and participates in the department's meetings (multidisciplinary consultation meeting (RCP), medical staff, medical-management meeting, etc.).
Reference centers
- Expert center for the management of autoimmune cytopenias (Head: Dr. Stéphane Chèze)
- Amyloidosis AL expert center; Dr P Gauberti/ Dr C Bauge
- Mastocytosis Expert Center; Prof. G. Damaj / Dr. Gauberti / Dr. Y. Ollivier / Dr. C. Morice
The lymph node pathway is a regional care pathway, centralized at the hematology institute of Lower Normandy, at the University Hospital of Caen, whose main objective is to allow a diagnosis and treatment in a rapid time of hematological pathologies of the lymphoma type.
This pathway links hematologists specializing in the diagnosis and treatment of lymphomas with various regional specialists essential to this care pathway.
Lymphomas encompass a group of several dozen pathologies. They are cancers of certain types of white blood cells, located in the lymph nodes, bone marrow, and blood. Other locations are possible.
The main warning sign suggesting lymphoma is the presence of a subcutaneous swelling, a lymph node, larger than 1.5 cm, painless, not red, and gradually increasing in size over several weeks to months. Common locations are the neck, under the armpits, or in the groin.
Other warning signs include an enlarged spleen (splenomegaly) or the presence of deep lymph nodes (lymphadenopathy) on an imaging examination (e.g., a CT scan).
The traditional healthcare pathway involves a consultation with a general practitioner or specialist who then refers the patient within the system.
It is also possible for any patient to contact us directly to make a consultation appointment (number below).
The waiting time before a first consultation is less than 7 days.
The standard diagnostic process, in cases of suspected lymphoma confirmed by a specialist physician, lasts 1 to 2 months and includes:
- A biopsy (surgical or radiological) within 1 to 3 weeks, with results then obtained in about two weeks.
- A PET scan in nuclear medicine.
- A cardiac evaluation by echocardiography or cardiac scintigraphy.
- Placement of a central venous catheter (via radiological or surgical approach)
- A blood test.
If the diagnosis is confirmed, treatment, which usually involves antibodies or chemotherapy products, begins shortly after the diagnosis is established.
All treatments are validated collectively in a multidisciplinary consultation meeting at the Normandy Basic Hematology Institute.
Doctors:
- Dr. Baptiste Delapierre
- Dr. Hippolyte Bardet
- Dr. Simon Laurent
Contact :
Ms. Séverine Colleville, coordinator
- 02 31 27 25 39
- colleville-s@chu-caen.fr
- fax: 02 31 27 24 79
Since 2008, the department and the Caen University Hospital have been committed to a quality improvement initiative called JACIE and obtained accreditation in December 2013 for a period of four years. This accreditation is granted by the European Accreditation Board for Hematopoietic Stem Cell Transplantation Centers after a three-day external audit.
The team analyzed the different stages of hematopoietic stem cell transplantation in adults. They developed and validated operational procedures covering the entire care pathway, from the pre-transplant visit to the transplant procedure itself, including potential complications. This accreditation aims to maintain high standards of patient care.
The accreditation was renewed on 06/02/2023 for 2 years and a new accreditation visit took place in 06/2026 with regard to the activities of autograft, allograft, apheresis, bone marrow collection and CAR-T cells.
Rare Disease Reference Center | Center page | |
Structure | Center page | |
Structure | Center page |
Women's and Children's Hospital - Hematology
Hematology
| Level | GPS access | Entrance | ||
|---|---|---|---|---|
Hematology Women's and Children's Hospital - Hematology | Level : 4 | GPS access: Main |  |
